Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Crinetics Pharmaceuticals Inc shares valued at $639,256 were sold by Pizzuti Dana on Apr 15 ’24. At $44.47 per share, Pizzuti Dana sold 14,375 shares. The insider’s holdings dropped to 27,786 shares worth approximately $1.2 million following the completion of this transaction.
Also, Struthers Richard Scott sold 40,951 shares, netting a total of over 2,013,561 in proceeds. Following the sale of shares at $49.17 each, the insider now holds 237,835 shares.
Before that, Okey Stephanie had sold 17,500 shares from its account. In a trade valued at $811,650, the Director traded Crinetics Pharmaceuticals Inc shares for $46.38 each. Upon closing the transaction, the insider’s holdings decreased to 17,500 shares, worth approximately $0.26 million.
As published in their initiating research note from Citigroup on March 06, 2024, Crinetics Pharmaceuticals Inc [CRNX] has been a Buy and the price target has been revised to $68. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid January. As of December 21, 2023, Jefferies has initiated its “Hold” rating for CRNX.
Analyzing CRNX Stock Performance
During the last five days, there has been a drop of approximately -10.45%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have jumped approximately 20.88%. Shares of the company reached a 52-week high of $49.58 on 04/04/24 and a 52-week low of $33.67 on 01/05/24. A 50-day SMA is recorded $42.18, while a 200-day SMA reached $31.20. Nevertheless, trading volume fell to 0.54 million shares from 0.47 million shares the previous day.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 42.41, which, if violated, would cause prices to drop to 41.80. In the upper region, resistance lies at 44.08. The next price resistance is at 45.14. RSI (Relative Strength Index) is 46.23 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.24, which suggests the price will decrease in the coming days. Percent R is at 94.53%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
